Rapid diagnoses of mycobacterial diseases, and their implication on clinical management

Danish Medical Bulletin

Volumn 53, Issue 1, 2006, Pages 28-45

  Johansen, Isik Somuncu ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; FORMALDEHYDE; ISONIAZID; PARAFFIN; QUINOLONE DERIVATIVE; RIFAMPICIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; COST EFFECTIVENESS ANALYSIS; DNA MICROARRAY; DNA SEQUENCE; DRUG EFFICACY; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; GENOTYPE; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LABORATORY TEST; LIGASE CHAIN REACTION; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; STANDARDIZATION; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

BACTERIOLOGICAL TECHNIQUES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 33644817297     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Review

References (218)

1. A study in Hong Kong to evaluate the role of pretreatment susceptibility test in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation. 1972. Am Rev Respir Dis 106: 1-22.
2. Adjers-Koskela, K. and M. L. Katila. 2003. Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis. J Clin Microbiol 41:1235-1239.
3. Ahmad, S., G. F. Araj, P. K. Akbar, E. Fares, T. D. Chugh, and A. S. Mustafa 2000. Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East. Diagn Microbiol Infect Dis 38:227-232.
4. Ahtja, G. K., K. K. Mohan, K. Prasad, and M. Behari. 1994. Diagnostic criteria for tuberculous meningitis and their validation. Tuber Lung Dis 75: 149-152.
5. Alagaden, G. J., B. N. Kreiswirth, A. Aouad, M. Khetarpal, F. R. Igno, S. I Moghazeh, E. K. Manavathu, and S. A. Lerner. 1998. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 42:1295-1297.
6. Alcide, F., G. E. Pfyffer, and A. Telenti. 1997. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother 41:2270-2273.
7. American Thoracic Society. 1997. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Resoir Crit Care Med 156:S1-25.
8. Andersen P. and Kock-Hansen G.H. 2003. Tuberculosis 2002, Part I. Epi News 44:1.
9. Andersen, P. and E. Smith. 2000. Tuberculosis 1999, Part I. Epi News 45:.
10. Antinori, S., L. Galimberti, and F. Parente. 2001. Intestinal tuberculosis as a cause of chronic diarrhoea among patients with human immunodeficiency virus infection: report of two cases. Dig Liver Dis 33:63-67.
11. Ardito, F., B. Posteraro, M. Sanguinetti, S. Zanetti, and G. Fadda. 2001. Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 39:4440-4444.
12. Auina, V., F. Gamboa, E. Gazapo, J. M. Manterola, J. Lonca, L. Matas, J. R. Manzano, C. Rodrigo, P. J. Cardona, and E. Padilla. 1997. Evaluation of the semiautomated Abbott LCx Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol 35:1996-2002.
13. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. S. Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
14. Barrett, A., J. G. Magee, and R. Freeman. 2002. An evaluation of the BD ProbeTec ET system for the direct detection of Mycobacteriurn tuberculosis in respiratory samples. J Med Microbiol 51:895-898.
15. Bartfai, Z., A. Somoskovi, C. Kodmon, N. Szabo, E. Puskas, L. Kosztolanyi, E. Farago, J. Mester, L. M. Parsons, and M. Salfinger. 2001. Molecular characterization of rifampin -resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 39:3736-3739.
16. Bauer, J., Z. Yang, S. Poulsen, and A. B. Andersen. 1998. Results from 5 years of nationwide DNA fingerprinting of Mycobacterium tuberculosis complex isolates in a country with a low incidence of M. tuberculosis infection. J Chin Microbiol 36:305-308.
17. Behr, M. A., S. A. Warren, H. Salamon, P. C. Hopewell, d. L. Ponce, C. L. Daley, and P. M. Small. 1999. Transmission of Mycobacteriurn tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353:444-449.
18. Bemer, P., F. Palicova, S. Rusch-Gerdes, H. B. Drugeon, and G. E. Pfyffer. 2002. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 40:150-154.
19. Benator, D. A. and F. M. Gordin. 1996. Nontuberculous mycobacteria in patients with human immunodeficiency virus infection. Semin Respir Infect 11:285-300.
20. Berenguer, J., S. Moreno, F. Laguna, T. Vicente, M. Adrados, A. Ortega, J. Gonzalez-LaHoz, and E. Bouza. 1992. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 326:668-672.
21. Bergmann, J. S., W. E. Keating, and G. L. Woods. 2000. Clinical evaluation of the BDProbeTec ET system for rapid detection of Mycobacterium tuberculosis. J Clin Microbiol 38:863-865.
22. Bergmann, J. S. and G. L. Woods. 1998. Evaluation of the ESP culture system II for testing susceptibilities of Mycobacteriurn tuberculosis isolates to four primary antituberculous drugs. J Clin Microbiol 36:2940-2943.
23. Berk, R. H., M. Yazici, N. Atabey, O. S. Ozdamar, U. Pabuccuoglu, and E. Alici. 1996. Detection of Mycobacterium, tuberculosis in formaldehyde solution-fixed, paraffin-embedded tissue by polymerase chain reaction in Pott's disease. Spine 21:1991-1995.
24. Bidstrup, C., P. H. Andersen, P. Skinhoj, and A. B. Andersen. 2002. Tuberculous meningitis in a country with a low incidence of tuberculosis: still a serious disease and a diagnostic challenge. Scand J Infect Dis 34: 811-814.
25. Bottger, E. C., A. Teske, P. Kirschner, S. Bost, H. R. Chang, V. Beer, and B. Hirschel, 1992. Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet 340:76-80.
26. Brisson-Noel, A., C. Aznar, C. Chureau, S. Nguyen, C. Pierre, M. Bartoli, R. Bonete, G. Pialoux, B. Gicquel, and G. Garrigue. 1991. Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation. Lancet 338:364-366.
27. Brock, I., K. Weldingh, T. Lillebaek, F. Follmann, and P. Andersen. 2004. Comparison of a New Specific Blood Test and the Skin Test in Tuberculosis Contacts. Am J Respir Crit Care Med 170(1):65-69.
28. Burman, W. J. and B. E. Jones. 2003. Clinical and radiographic features of HIV-related tuberculosis. Semin Respir Infect 18:263-271.
29. Butler, W. R. and L. S. Guthertz. 2001. Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin Microbiol Rev 14:704-26 (table).
30. Bux-Gewehr, I., H. P. Hagen, S. Rusch-Gerdes, and G. E. Feurle. 1998. Fatal pulmonary infection with Mycobacterium celatum in an apparently immunocompetent patient. J Clin Microbiol 36:587-588.
31. Canetti, G. 1965. Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis 92:687-703.
32. Canetti, G., W. Fox, A. Khomenko, H. T. Mahler, N. K. Menon, D. A. Mitchison, N. Rist, and N. A. Smelev. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 41:21-43.
33. Canetti, G., S. Froman, J. Grosset, P. Hauduroy, M. Langerova, H.T. Mahler, G. Meissner, D.A. Mitchison, and L. SULA. 1963. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 29:565-578.
34. Center for Disease Control. 2000. Notice to Readers: Update: Nucleic Acid Amplification Tests for Tuberculosis. MMWR Morb Mortal Wkly Rep 49:593-594.
35. Center for Disease Control. Epidemiologic notes and reports nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. 40, 585-591. 2002.
36. Center for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system New York, 1991. 41, 507-509. 2002.
37. Chedo e, P. and F. B. Jamieson. 2002. Rapid molecular diagnosis of tuberculous meningitis using the Gen-probe Amplified Mycobacterium Tuberculosis direct test in a large Canadian public health laboratory. Int J Tuberc Lung Dis 6:913-919.
38. Chin, P., A. L. Reingold, E. N. Stone, E. Vittinghoff, C. R. Horsburgh, Jr., E. M. Simon, D. M. Yajko, W. K. Hadley, S. M. Ostroff, and P. C. Hopewell. 1994. The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients - a prospective study. J Infect Dis 170:578-584.
39. Coll, P. M. Garrigo, C. Moreno, and N. Marti. 2003. Routine use of Geri-Probe Amplified Mycobacterium Tuberculosis Direct (MTD) test for detection of Mycobacteriurn tuberculosis with smear-positive and smear negative specimens. Int J Tuberc Lung Dis 7:886-891.
40. Conway, H. 1964. Prevalence of drug resistance in previously untreated patients. United Statets Public Health Service Cooperative Investigation. Am Rev Respir Dis 89:327-336.
41. Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163:1009-1021.
42. Crow, H. E., C. T. King, C. E. Smith, R. F. Corpe, and I. Stergus. 1957. A limited clinical, pathologic, and epidemiologic study of patients with pulmonary lesions associated with atypical acid-fast bacilli in the sputum. Am Rev Tuberc 75:199-222.
43. Daniel T. M. 1990. The rapid diagnosis of tuberculosis: a selective review. J Lab Clin Med 116:277-282.
44. Dass, L., T. A. Puet, and C. Watanakunakorn. 2002. Tuberculosis of the spine (Pott's disease) presenting as "compression fractures". Spinal Cord 40:604-608.
45. De Wi, D., I., Steyn, S. Shoemaker, and M. Sogin. 1990. Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification. J Clin Microbiol 28:2437-2441.
46. Diaz, M. L., T. Herrera, Y. Lopez-Vidal, J. J. Calva, R. Hernandez, G. R. Palacios, and E. Sada. 1996. Polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA in tissue and assessment of its utility in the diagnosis of hepatic granulomas. J Lab Clin Med 127:359-363.
47. Diaz-Infantes, M. S., M. J. Ruiz-Serrano, L. Martinez-Sanchez, A. Ortega, and E. Bouza. 2000. Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis. J clin Microbiol 38:1988-1989.
48. Dye, C, M. A. Espinal, C. J. Watt, C. Mbiaga, and B. G. Williams. 2002. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 185:1107-1202.
49. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686.
50. Eing, I. R., A. Becker, A. Sohns, and R. Ringelmann. 1998. Comparison of Roche Cobas Amplicor Mycobacterium tuberculosis assay with inhouse PCR and culture for detection of M. tuberculosis. J Clin Microbiol 36: 2023-2029.
51. Eisenach, K. D., M. D. Sifford, M. D. Cave, J. H. Bates, and J. T. Crawford. 1991. Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction. Am Rev Respir Dis 144:1160-1163.
52. Espina, M. A., A. Laszlo, L. Simonsen, F. Boulahbal, S. J. Kim, A. Reniero, S. Hoffner, H. L. Rieder, N. Binkin, C. Dye, R. Williams, and M. C. Raviglione. 2001. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 344:1294-1303.
53. Ewer, K., J. Deeks, L. Alvarez, G. Bryant, S. Waller, P. Andersen, P. Monk, and A. Lalvani. 2003. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361:1168-1173.
54. Falkinham, J. O,, III. 1996. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9:177-215.
55. Frieden, T. R., T. Sterling, A. Pablos-Mendez, J. O. Kilburn, G. M. Cauthen, and S. W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 328:521-526.
56. Fujiwara, T., Y. Yoshida, S. Yamada, H. Kawamata, T. Fujimori, and M. Imawari. 2003. A case of primary esophageal tuberculosis diagnosed by identification of Mycobacteria in paraffin-embedded esophageal biopsy specimens by polymerase chain reaction. J Gastroenterol 38:74-78.
57. Gamboa, F., G. Fernandez, E. Padilla, J. M. Manterola, J. Lonca, P. J. Cardona, L. Matas, and V. Ausina. 1998. Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 36:684-689.
58. Garrio, M. G., Y. Glupczynski, J. Degraux, H. Nizet, and M. Delmee. 1999. Evaluation of the Abbott LCx Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in human samples. J Clin Microbiol 37:229-232.
59. Geerligs, W. A., R. Van Altena, W. C. M. De Lange, D. van Soolingen, and T. S. Van Der Werf. 2000. Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands. Int J Tuberc Lung Dis 4:758-764.
60. Goelz, S. E., S. R. Hamilton, and B. Vogelstein. 1985. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 130:118-126.
61. Good, R. C. and D. E. Snider, Jr. 1982. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 146:829-833.
62. Hanna, B. A., A. Ebrahimzadeh, L. B. Elliott, M. A. Morgan, S. M. Novak, S. Rusch-Gerdes, M. Acio, D. F. Dunbar, T. M. Holmes, C. H. Rexer, C. Savthyakumar, and A. M. Vannier. 1999. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol 37:748-752.
63. Hardman, W. J., G. M. Benian, T. Howard, J. E. McGowan, Jr., B. Metchock, and J. J. Murtagh. 1996. Rapid detection of mycobacteria in inflammatory necrotizing granulomas from formalin-fixed, paraffin-embedded tissue by PCR in clinically high-risk patients with acid-fast stain and culture-negative tissue biopsies. Am J Clin Pathol 106:384-389.
64. Hargreaves, N. J., O. Kadzakumanja, C. J. Whitty, F. M. Salaniponi, A. D. Harries, and S. B. Squire. 2001. "Smear-negative" pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis 5:847-854.
65. Harries, A. D., H. T. Banda, M. J. Boeree, S. Welby, J. J. Wirima, V. R. Subramanyam, D. Maher, and P. Nunn. 1998. Management of pulmonary tuberculosis suspects with negative sputum smears and normal or minimally abnormal chest radiographs in resource-poor settings. Int J Tuberc Lung Dis 2:999-1004.
66. Harries, A. D., T. E. Nyirenda, A. Banerjee, M. J. Boeree, and F. M. Salaniponi. 1999. Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi. Trans R Soc Trop Med Hyg 93:443-446.
67. Heifets, L. B., P. J. Lindholm-Levy, and M. D. Iseman. 1988. Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis. Am Rev Respir Dis 137:719-721.
68. Hellyer, T. J., T. W. Fletcher, J. H. Bates, W. W. Stead, G. L. Templeton, M. D. Cave, and K. D. Eisenach. 1996. Strand displacement amplification and the polymerase chain reaction for monitoring response to treatment in patients with pulmonary tuberculosis. J Infect Dis 173: 934-941.
69. Hernandez-Pando, R., M. Jeyanathan, G. Mengistu, D. Aguilar H. Orozco, M. Harboe, G. A. Rook, and G. Bjune. 2000. Persistence of DNA from Mycobacteriurn tuberculosis in superficially normal lung tissue during latent infection. Lancet 356:2133-2138.
70. Hirano, K., C. Abe, and M. Takahashi. 1999. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol 37:2663-2666.
71. Horsburgh, C. R., Jr. and R. M. Selik. 1989. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 139:4-7.
72. Hosoglu, S., M. F. Geyik, I. Balik, B. Aygen, S. Erol, T. G. Aygencel, A. Mert, N. Saltoglu, I. Dokmetas, S. Felek, M. Sunbul, H. Irmak, K. Aydin, O. F. Kokoglu, H. Ucmak, M. Altindis, and M. Loeb. 2002. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 6:64-70.
73. Iinuma, Y., K. Senda, N. Fujihara, T. Saito, S. Takakura, M. Shimojima, T. Kudo, and S. Ichiyama. 2003. Comparison of the BDProbeTec ET system with the Cobas Amplicor PCR for direct detection of Mycobacterium tuberculosis in respiratory samples. Eur J Clin Microbiol Infect Dis 22:368-371.
74. Ingram, C. W., D. C. Tanner, D. T. Durack, G. W. Kernodle, Jr., and G. R. Corey. 1993. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 16:463-471.
75. Jesus, d. I. C., I, Jesus de la Calle MA, and M. Rodriguez-Iglesias. 2003. Evaluation of the BDProbeTec ET system as screening tool in the direct detection of mycobacterium tuberculosis complex in respiratory specimens. Diagn Microbiol Infect Dis 47:573-578.
76. Johansen, I. S. and V. Ø. Thomsen. 2000. Tuberculosis 1999, Part II, Drug resistance. Epi-News 46:1-2.
77. Jost, K. C., Jr., D. F. Dunbar, S. S. Barth, V. L. Headley, and L. B. Elliott. 1995. Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models. J Clin Microbiol 33:1270-1277.
78. Kasai, H., T. Ezaki, and S. Harayama. 2000. Differentiation of phylogenetically related slowly growing mycobacteria by their gyrB sequences. J Clin Microbiol 38:301-308.
79. Kim, B. J., S. H. Lee, M. A. Lyu, S. J. Kim, G. H. Bai, G. T. Chae, E. C. Kim, C. Y. Cha, and Y. H. Kook. 1999. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol 37:1714-1720.
80. Kirchner, P., B. Springer, U. Vogel, A. Meier, A. Wrede, M. Kiekenbeck, F. Bange, and E. C. Bottger. 1993. Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol 31:2882-2889.
81. Kruner, A., S. E. Hoffner, H. Sillastu, M. Danilovits, K. Levina, S. B. Svenson, S. Ghebremichael, T. Koivula, and G. Kallenius. 2001. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 39:3339-3345.
82. Kwoh, D. Y., G. R. Davis, K. M. Whitfield, H. L. Chappelle, L. J. DiMichele, and T. R. Gingeras. 1989. Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format. Proc Natl Acad Sci USA 86:1173-1177.
83. Lang, A. M., J. Feris-Iglesias, C. Pena, J. F. Sanchez, L. Stockman, P. Rys, G. D. Roberts, N. K. Henry, D. H. Persing, and F. R. Cockerill, III. 1998. Clinical evaluation of the Gen-Probe Amplified Direct Test for detection of Mycobacterium tuberculosis complex organisms in cerebrospinal fluid. J Clin Microbiol 36:2191-2194.
84. Laszlo, A., M. Rahman, M. Espinal, and M. Raviglione. 2002. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network; five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 6:748-756.
85. Laszlo, A., M. Rahman, M. Raviglione, and F. Bustreo. 1997. Quality assurance programme for drug susceptibility testing of Mycobacterium, tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis 1:231-238.
86. Lebrun, L., F. Espinasse, J. D. Poveda, and V. Vincent-Levy-Frebault. 1992. Evaluation of nonradioactive DNA probes for identification of mycobacteria. J Clin Microbiol 30:2476-2478.
87. Lehmann, U., S. Glockner, W. Kleeberger, H. F. von Wasielewski, and H. Kreipe. 2000. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am J Pathol 156:1855-1864.
88. Lewis, F., N. J. Maughan, V. Smith, K. Hillan, and P. Quirke. 2001. Unlocking the archive - gene expression in paraffin-embedded tissue. J Pathol. 195:66-71.
89. Li, J. Y., S. T. Lo, and C. S. Ng. 2000. Molecular detection of Mycobacterum tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli. Diagn Mol Pathol 9:67-74.
90. Liliebaek, T, Dirksen, A, Kok-Jensen, A., and Andersen, A. B. 20004. Dominant Mycobacterium tuberculosis strain emerging rapidly in Denmark. Int J Tuberc Lung Dis 8(8), in press.
91. Liliebaek, T., A. B. Andersen, A. Dirksen, E. Smith, L. T. Skovgaard, and A. Kok-Jensen. 2002. Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg Infect Dis 8:679-684.
92. Lirdbrathen, A., P. Gaustad, B. Hovig, and T. Tonjum. 1997. Direct detection of Mycobacterium tuberculosis complex in clinical samples from patients in Norway by ligase chain reaction. J Clin Microbiol 35:3248-3253.
93. Lipsky, B. A., J. Gates, F. C. Tenover, and J. J. Plorde. 1984. Factors affecting the clinical value of microscopy for acid-fast bacilli. Rev Infect Dis 6:214-222.
94. Lo S. F., A. K. Ahchong, C. N. Tang, and A. W. Yip. 1998. Pancreatic tuberculosis: case reports and review of the literature. J R Coll Surg Edinb 43:65-68.
95. Lu C. Z., J. Qiao, T. Shen, and H. Link. 1990. Early diagnosis of tuberculous meningitis by detection of anti-BCG secreting cells in cerebrospinal fluid. Lancet 336:10-13.
96. Lund, R. J., M. J. Koch, J. B. Oldemeyer, A. J. Meares, and R. W. Dunlay. 2000. Extrapulmonary tuberculosis in patients with end stage renal disease - two case reports and a brief review. Int Urol Nephrol 32:181-183.
97. MacDonell, K. B. and J. Glassroth. 1989. Mycobacterium avium complex and other nontuberculous mycobacteria in patients with HIV infection. Semin Respir Infect 4:123-132.
98. Madison, B., B. Robinson-Dunn, I. George, W. Gross, H. Lipman, B. Matchock, A. Sloutsky, G. Washabaugh, G. Mazurek, and J. Ridderhof. 2002. Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods. J Clin Microbiol 40:3976-3979.
99. Makinen, J., A. Sarkola, M. Marjamaki, M. K. Viljanen, and H. Soini. 2002. Evaluation of genotype and LiPA Mycobacteria assays for identification of Finnish mycobacterial isolates. J Clin Microbiol 40:3478-3481.
100. Mangione, E. J., G. Huitt, D. Lenaway, J. Beebe, A. Bailey, M. Figoski, M. P. Rau, K. D. Albrecht, and M. A. Yakrus. 2001. Nontuberculous mycobacterial disease following hot tub exposure. Emerg Infect Dis 7:1039-1042.
101. Maugein, J., J. Fourche, S. Vacher, C. Grimond, and C. Bebear. 2002. Evaluation of the BDProbeTec ET DTB assay (1) for direct detection of Mycobacterium tuberculosis complex from clinical samples. Diagn Microbiol Infect Dis 44:151-155.
102. Mazurek, G. H. and M. E. Villarino. 2003. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 52:15-18.
103. Mazzarelli, G., L. Rindi, P. Piccolli, C. Scarparo, C. Garzelli, and E. Tortoli. 2003. Evaluation of the BDProbeTec ET system for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary samples: a multicenter study. J Clin Microbiol 41:1779-1782.
104. Mdluli, K., R. A. Slayden, Y. Zhu, S. Ramaswamy, X. Pan, D. Mead, D. D. Crane, J. M. Musser, and C. E. Barry, III. 1998. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science 280:1607-1610.
105. Mies, C. 1994. Molecular biological analysis of paraffin-embedded tissues. Hum Pathol 25:555-560.
106. Migliori, G. B. and R. Centis. 2002. Problems to control TB in eastern Europe and consequences in low incidence countries. Monaldi Arch Chest Dis 57:285-290.
107. Miller, N., S. Infante, and T. Cleary. 2000. Evaluation of the LiPA Mycobacteria assay for identification of mycobacterial species from BACTEC 12B bottles. J Clin Microbiol 38:1915-1919.
108. Miorner, H., U. Sjobring, P. Nayak, and A. Chandramuki. 1995. Diagnosis of tuberculous meningitis: a comparative analysis of 3 immuno-assays, an immune complex assay and the polymerase chain reaction. Tuber Lung Dis 76:381-386.
109. Mori, T., M. Sakatani, F. Yamagishi, T. Takashima, Y. Kawabe, K. Nagao, E. Shigeto, N. Haraida, S. Mitarai, M. Okada, K. Suzuki, Y. Inoue, K. Tsuyuguchi, Y. Sasaki, G. H. Mazurek, and I. Tsuyuguchi. 2004. Specific Detection of Tuberculosis Infection with an Interferon-gamma Based Assay Using New Antigens. Am J Respir Crit Care Med 170:59-64.
110. Morlock, G. P., B. Metchock, D. Sikes, J. T. Crawford, and R. C. Cooksey. 2003. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 47:3799-3805.
111. Morozova, I., V. Riekstina, G. Sture, C. Wells, and V. Leimane. 2003. Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. Int J Tuberc Lung Dis 7:903-906.
112. Musser, J. M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 8:496-514.
113. Myojo, M., S. Fujiuchi, H. Matsumoto, Y. Yamazaki, M. Takahashi, K. Satoh, A. Takeda, Y. Nishigaki, K. Okamoto, Y. Fujita, T. Fujikane, and T. Shimizu. 2003. Disseminated Mycobacterium avium, complex (DMAC) in an immunocompetent adult Int J Tuberc Lung Dis 7:498-501.
114. Niemann, S., D. Harmsen, S. Rusch-Gerdes, and E. Richter. 2000. Differentiation of clinical Mycobacterium tuberculosis complex isolates by gyrB DNA sequence polymorphism analysis. J Clin Microbiol 38:3231-3234.
115. Noordhoek, G. T., S. Mulder, P. Wallace, and A. M. van Loon. 2004. Multicentre quality control study for detection of Mycobacterium tuberculosis in clinical samples by nucleic amplification methods. Clin Microbiol Infect 10:295-301.
116. Noordhoek, G. T., J. D. Van Embden, and A. H. Kolk. 1996. Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol 34:2522-2525.
117. O'Sullivan, C. E., D. R. Miller, P. S. Schneider, and G. D. Roberts. 2002. Evaluation of Gen-Probe amplified mycobacterium tuberculosis direct test by using respiratory and nonrespiratory specimens in a tertiary care center laboratory. J Clin Microbiol 40:1723-1727.
118. Pablos-Mendez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rieder, F. Bustreo, D. L. Cohn, C. S. Lambregs-van Weezenbeek, S. J. Kim, P. Chaulet, and P. Nunn. 1998. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 338:1641-1649.
119. Pablos-Mendez, A., T. R. Sterling, and T. R. Frieden. 1996. The relationship between delayed or incomplete treatment and all-cause mortality in-patients with tuberculosis. JAMA 276:1223-1228.
120. Pai, M., L. L. Flores, N. Pai, A. Hubbard, L. W. Riley, and J. M. Colford, Jr. 2003. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 3:633-643.
121. Palmieri, F., E. Girardi, A. M. Pellicelli, A. Rianda, E. Bordi, E. B. Rizzi, N. Petrosillo, and G. Ippolito. 2002. Pulmonary tuberculosis in HIV-infected patients presenting with normal chest radiograph and negative sputum smear. Infection 30:68-74.
122. Park, M. M., A. L. Davis, N. W. Schluger, H. Cohen, and W. N. Rom. 1996. Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy. Am J Respir Crit Care Med 153:317-324.
123. Perlman, D. C., P. El Helou, and N. Salomon. 1999. Tuberculosis in patients with human immunodeficiency virus infection. Semin Respir Infect 14:344-352.
124. Perosio, P. M. and T. S. Frank. 1993. Detection and species identification of mycobacteria in paraffin sections of lung biopsy specimens by the polymerase chain reaction. Am J Clin Pathol 100:643-647.
125. Pfyffe, G. F., D. A. Bonato, A. Ebrahimzadeh, W. Gross, J. Hotaling, J. Kornllum, A. Laszlo, G. Roberts, M. Salfinger, F. Wittwer, and S. Siddiqi. 1999. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol 37:3179-3186.
126. Pfyffe, G. E., B. A. Brown-Elliott, and R. J. Wallace Jr. 2003. Mycobacterium: General Characteristics, isolation, and staining procedures, p. 532-559. In: P. R. Murray, E. J. Baron, J. Jorgensen, M. A. Pfaller, and R. H. Yo ken (eds.), Manual of Clinical Microbiology. ASM Press, Washington, DC.
127. Pfyffe, G. E., F. Palicova, and S. Rusch-Gerdes. 2002. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system. J Clin Microbiol 40:1670-1674.
128. Piersinoni, C., A. Callegaro, C. Scarparo, V. Penati, D. Nista, S. Bornigia, C. Lacchini, M. Scagnelli, G. Santini, and G. De Sio. 1998. Comparative evaluation of the new gen-probe Mycobacterium tuberculosis amplified direct test and the semiautomated abbott LCx Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in respiratory and extrapulmonary specimens. J Clin Microbiol 36:3601-3604.
129. Piersimoni, C. and C. Scarparo. 2003. Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol 41:5355-5365.
130. Piersimoni, C., C. Scarparo, A. Callegaro, C. P. Tosi, D. Nista, S. Bornigia, M. Scagnelli, A. Rigon, G. Ruggiero, and A. Goglio. 2001. Comparison of MB/Bact alert 3D system with radiometric BACTEC system and Lowenstein-Jensen medium for recovery and identification of mycobacteria from clinical specimens: a multicenter study. J Clin Microbiol 39:651-657.
131. Piersimoni, C., C. Scarparo, P. Piccoli, A. Rigon, G. Ruggiero, D. Nista, and S. Bornigia. 2002. Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimens. J Clin Microbiol 40:4138-4142.
132. Piersimoni, C., P. G. Zitti, D. Nista, and S. Bornigia. 2003. Mycobacterium celatum pulmonary infection in the immunocompetent: case report and review. Emerg Infect Dis 9:399-402.
133. Plikaytis, B. B., B. D. Plikaytis, M. A. Yakrus, W. R. Butler, C. L. Woodley, V. A. Silcox, and T. M. Shinnick. 1992. Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol 30:1815-1822.
134. Porkert, M. T., M. Sotir, P. Parrott-Moore, and H. M. Blumberg. 1997. Tuberculous meningitis at a large inner-city medical center. Am J Med Sci 313:325-331.
135. Poulsen, S., T. Ronne, A. Kok-Jensen, J. O. Bauer, and H. Miorner. 1999. [Tuberculosis in Denmark 1972-1996]. Ugeskr Læger 161:3452-3457.
136. Qian, L., J. D. Van Embden, A. G. Van Der Zanden, E. F. Weltevreden, H. Duanmu, and J. T. Douglas. 1999. Retrospective analysis of the Beijing family of Mycobacterium tuberculosis in preserved lung tissues. J Clin Microbiol 37:471-474.
137. Raviglione, M. C. 2003. The TB epidemic from 1992 to 2002. Tuberculosis (Edinb.) 83:4-14.
138. Reischl, U., N. Lehn, H. Wolf, and L. Naumann. 1998. Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol 36:2853-2860.
139. Ringuet, H., C. Akoua-Koffi, S. Honore, A. Varnerot, V. Vincent, P. Berche, J. L. Gaillard, and C. Pierre-Audigier. 1999. hsp65 sequencing for identification of rapidly growing mycobacteria. J Clin Microbiol 37: 852-857.
140. Rish, I. A., K. D. Eisenach, M. D. Cave, M. V. Reddy, P. R. Gangadharam, and J. H. Bates. 1996. Polymerase chain reaction detection of Mycobacterium tuberculosis in formalin-fixed tissue. Am J Respir Crit Care Med 153:1119-1423.
141. Ristow, M., M. Mohlig, M. Rifai, H. Schatz, K. Feldmann, and A. Pfeiffer. 1995. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet 346:502-503.
142. Rodriguez, E., R. Soler, A. Juffe, and L. Salgado. 2001. CT and MR findings a calcified myocardial tuberculoma of the left ventricle. J Comput Assist Tomogr 25:577-579.
143. Rossau, R., H. Traore, H. De Beenhouwer, W. Mijs, G. Jannes, P. De Rijk, and F. Portaels. 1997. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin, Anti-microb Agents Chermother 41:2093-2098.
144. Roth, A., M. Fischer, M. E. Hamid, S. Michalke, W. Ludwig, and H. Mauch. 1998. Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. J Clin Microbiol 36:139-147.
145. Roth, A., U. Reischl, A. Streubel, L. Naumann, R. M. Kroppenstedt, M. Habicht, M. Fischer, and H. Mauch. 2000. Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases. J Clin Microbiol 38:1094-1104.
146. Ruiz, P., J. Gutierrez, F. J. Zerolo, and M. Casal. 2002. GenoType mycobacterium assay for identification of mycobacterial species isolated from human clinical samples by using liquid medium. J Clin Microbiol 40:3076-3078.
147. Ruiz, P., F J. Zerolo, and M. J. Casal. 2000. Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method. J Clin Microbiol 38:4663-4664.
148. Ruiz-Manzano, J., J. M. Manterola, F. Gamboa, A. Calatrava, E. Monso, C. Martinez, and V. Ausina. 2000. Detection of mycobacterium tuberculosis in paraffin-embedded pleural biopsy specimens by commercial ribosomal RNA and DNA amplification kits. Chest 118:648-655.
149. Rusch-Gerdes, S. and E. Richter. 2004. Clinical evaluation of the semi-automated BDProbe Tec ET System for the detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. Diagn Microbiol Infect Dis 48:265-270.
150. Saiki, R. K., D. H. Gelfand, S. Stoftel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
151. Salian, N. V., J. A. Rish, K. D. Eisenach, M. D. Cave, and J. H. Bates. 1998. Polymerase chain reaction to detect Mycobacterium tuberculosis in histologic specimens. Am J Respir Crit Care Med 158:1150-1155.
152. Scarparo, C., P. Piccoli, A. Rigon, G. Ruggiero, D. Nista, and C. Piersimoni. 2001. Direct identification of mycobacteria from mb/bact alert 3d bottles: comparative evaluation of two commercial probe assays. J Clint Microbiol 39:3222-3227.
153. Scarparo, C., P. Piccoli, A. Rigon, G. Ruggiero, P. Ricordi, and C. Piersimoni. 2002. Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimens. Diagn Microbiol Infect Dis 44:157-161.
154. Scarparo, C., P. Piccoli, A. Rigon, G. Ruggiero, M. Scagnelli, and C. Piersimoni. 2000. Comparison of enhanced Mycobacterium tuberculosis amplified direct test with COBAS AMPLICOR Mycobacterium tuberculosis assay for direct detection of Mycobacterium, tuberculosis complex in respiratory and extrapulmonary specimens. J Clin Microbiol 38:1559-1562.
155. Scorpio, A., P. Lindholm-Levy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynamon, and Y. Zhang. 1997. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 41:540-543.
156. Selva, E., V. Hofman, F. Berto, S. Musso, L. Castillo, J. Santini, P. Dellamonica, and P. Hofmnan. 2004. The value of polymerase chain reaction detection of Mycobacterium tuberculosis in granulomas isolated by laser capture microdissection. Pathology 36:77-81.
157. Siddiqi, S. H. BACTEC 460 TB System. Product and Procedure Manual. 1996. Becton Dickinson Microbiology Systems, Sparks, Md.
158. Siddiqi, S. H., J. E. Hawkins, and A. Laszlo. 1985. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol 22:919-923.
159. Small, P. M., G. F. Schecter, P. C. Goodman, M. A. Sande, R. E. Chaisson, and P. C. Hopewell. 1991. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 324:289-294.
160. Smith, M. B., M. C. Boyars, S. Veasey, and G. L. Woods. 2000. Generalized tuberculosis in the acquired immune deficiency syndrome. Arch Pathol Lab Med 124:1267-1274.
161. Soini, H., E. C. Bottger, and M. K. Viljanen. 1994. Identification of mycobacteria by PCR-based sequence determination of the 32-kilodalton protein gene. J Clin Microbiol 32:2944-2947.
162. Somoskovi, A., C. Kodmon, A. Lantos, Z. Bartfai, L. Tamasi, J. Fuzy, and P. Magyar. 2000. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium. J Clin Microbiol 38:2395-2397.
163. Spargo, C. A., M. S. Fraiser, M. Van Cleve, D. J. Wright, C. M. Nycz, P. A. Spears, and G. T. Walker. 1996. Detection of M. tuberculosis DNA using thermophilic strand displacement amplification. Mol Cell Probes 10:247-256.
164. Springer, B., L. Stockman, K. Teschner, G. D. Roberts, and E. C. Bottger. 1999. Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbiol 34:296-303.
165. Srecvatsan, S., X. Pan, Y. Zhang, B. N. Kreiswirth, and J. M. Musser. 1997. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother 41:636-640.
166. Srevatsan, S., K. E. Stockbauer, X. Pan, B. N. Kreiswirth, S. L. Moghazeh W. R. Jacobs, Jr., A. Telenti, and J. M. Musser. 1997. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 41:1677-1681.
167. Suys, P. N., R. A. da Silva, M. de Oliveira, C. E. Campos, A. M. Barreto, F. Fortaels, L. Rigouts, G. Wouters, G. Jannes, G. van Reybroeck, W. Mijs, and B. Vanderborght. 2001. Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay. J Clin Microbiol 39:4477-4482.
168. Suzuki, Y., C. Katsukawa, A. Tamaru, C. Abe, M. Makino, Y. Mizuguchi, and H. Taniguchi. 1998. Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol 36:1220-1225.
169. Tahoglu, K., T. Torun, T. Sevim, G. Atac, A. Kir, L. Karasulu, I. Ozmen, and N. Kapakli. 2001. The treatment of multidrug-resistant tuberculosis in Turkey. N EngI J Med 345:170-174.
170. Takewaki, S., K. Okuzumi, I. Manabe, M. Tanimura, K. Miyamura, K. Nalahara, Y. Yazaki, A. Ohkubo, and R. Nagai. 1994. Nucleotide sequence comparison of the mycobacterial dnaJ gene and PCR-restriction fragment length polymorphism analysis for identification of mycobacterial species. Int J Syst Bacteriol 44:159-166.
171. Takiff, H. E., L. Salazar, C. Guerrero, W. Philipp, W. M. Huang, B. Kreisworth, S. T. Cole, W. R. Jacobs, Jr., and A. Telenti. 1994. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 38:773-780.
172. Telnti, A., N. Honore, C. Bernasconi, J. March, A. Ortega, B. Heym, H. E. Takiff, and S. T. Cole. 1997. Genotypic assessment of isoniazid and rifan pin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 35:719-723.
173. Telnti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Ma ter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
174. Telonti, A., F. Marchesi, M. Balz, F. Bally, E. C. Bottger, and T. Bodmer. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 31:175-178.
175. Tenover, F. C., J. T. Crawford, R. E. Huebner, L. J. Geiter, C. R. Horsburgh, Jr., and R. C. Good. 1993. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol 31:767-770.
176. The National Committee for Clinical Laboratory Standards. 2003. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard M24-A, p. 1-84. Pennsylvania, USA.
177. Thomsen, V. Ø. 2003. Tuberculosis 2002 Part III. Epi-News 47:1.
178. Thomsen, V. O., A. B. Andersen, and H. Miorner. 2002. Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey. Scand J Infect Dis 34:648-653.
179. Thomsen, V. O., J. Bauer, T. Lillebaek, and S. Glismann. 2000. Results from 8 yrs of susceptibility testing of c1inical Mycobacterium tuberculosis isolates in Denmark. Eur Respir J 16:203-208.
180. Thomsen, V. O., U. B. Dragsted, J. Bauer, K. Fuursted, and J. Lundgren. 1999. Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. J Clin Microbiol 37:3901-3905.
181. Thomsen, V. O., A. Kok-Jensen, M. Buser, S. Philippi-Schulz, and H. J. Burkardt. 1999. Monitoring treatment of patients with pulmonary tuberculosis: can PCR be applied? J Clin Microbiol 37:3601-3607.
182. Thomsen, VØ and Andersen, P. Tuberculosis 2000, part II. 1. 2001. EPI-News.
183. Thomson, R. B., Jr. and H. Bertram. 2001. Laboratory diagnosis of central nervous system infections. Infect Dis Clin North Am 15:1047-1071.
184. Thwaites, G. E., M. Caws, T. T. Chau, N. T. Dung, J. I. Campbell, N. H. Phu, T. T. Hien, N. J. White, and J. J. Farrar. 2004. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol 42:996-1002.
185. Thwaites, G. E., T. T. Chau, and J. J. Farrar. 2004. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 42:378-379.
186. Thwaites, G. E., T. T. Chau, K. Stepniewska, N. H. Phu, L. V. Chuong, D. X. Sinh, N. J. White, C. M. Parry, and J. J. Farrar. 2002. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 360:1287-1292.
187. Timpe, A. and E. H. Runyon. 1954. The relationship of atypical acid-fast bacteria to human disease; a preliminary report. J Lab Clin Med 44:202-209.
188. Tjhie, J. H., A. F. van Belle, M. Dessens-Kroon, and D. van Soolingen. 2001. Misidentification and diagnostic delay Caused by a false-positive amplified Mycobacterium tuberculosis direct test in an immunocompetent patient with a Mycobacterium, celatum infection. J Clin Microbiol 39:2311-2312.
189. Tortoli, E. 2003. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 16:319-354.
190. Tortoli, E., M. Benedetti, A. Fontanelli, and M. T. Simonetti. 2002. Evaluation of Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to Four Major Antituberculous Drugs: Comparison with the Radiometric BACTEC 460TB Method and the Agar Plate Method of Proportion. J Clin Microbiol 40:607-610.
191. Tortoli, E., P. Cichero, C. Piersimoni, M. T. Simonetti, G. Gesu, and D. Nista. 1999. Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J Clin Microbiol 37:3578-3582.
192. Tortoli, E., A. Mariottini, and G. Mazzarelli. 2003. Evaluation of INNO-LiPA Mycobacteria v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. J Clin Microbiol 41:4418-4420.
193. Tortoli, E., R. Mattei, A. Savarino, L. Bartolini, and J. Beet. 2000. Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems. Diagn Microbiol Infect Dis 38:83-86.
194. Tortoli, E., A. Nanetti, C. Piersimoni, P. Cichero, C. Farina, G. Mucignat, C. Scarparo, L. Bartolini, R. Valentini, D. Nista, G. Gesu, C. P. Tosi, M. Crovatto, and G. Brusarosco. 2001. Performance assessment of new multiplex probe assay for identification of mycobacteria. J Clin Microbiol 39:1079-1084.
195. Tortoli, E., M. Tronci, C. P. Tosi, C. Galli, F. Lavinia, S. Natili, and A. Goglio. 1999. Multicenter evaluation of two commercial amplification kits (Amplicor, Roche and LCx, Abbott) for direct detection of Myrobacterium tuberculosis in pulmonary and extrapulmonary specimens. Diagn Microbiol Infect Dis 33:173-179.
196. Tracevska, T., I. Jansone, L. Broka, O. Marga, and V. Baumanis. 2002. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol 40:3789-3792.
197. Turett, G. S., E. E. Telzak, L. V. Torian, S. Blum, D. Alland, I. Weisfuse, and B. A. Fazal. 1995. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin Infect Dis 21:1238-1244.
198. van Crevel, R., W. C. de Lange, N. A. Vanderpuye, D. van Soolingen, J. A. Hoogkamp-Korstanje, K. M. van Deuren, B. J. Kullberg, C. van Herwaarden, and J. W. van der Meer. 2001. The impact of nontuberculous mycobacteria on management of presumed pulmonary tuberculosis. Infection 29:59-63.
199. van Soolingen, D., P. E. de Haas, P. W. Hermans, P. M. Groenen, and J. D. Van Embden. 1993. Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol 31:1987-1995.
200. Verdon, R., S. Chevret, J. P. Laissy, and M. Wolff. 19996. Tuberculous meningitis in adults: review of 48 cases. Clint Infect Dis 22:982-988.
201. Viskum, K. and A. Kok-Jensen. 1997. Multidrug-resistant tuberculosis in Denmark 1993-1995. Int J Tuberc Lung Dis 1:299-301.
202. Walker, G. T., J. G. Nadeau, P. A. Spears, J. L. Schram, C. M. Nycz, and D. D. Shank. 1994. Multiplex strand displacement amplification (SDA) and detection of DNA sequences from Mycobacterium, tuberculosis and oher mycobacteria. Nucleic Acids Res 22:2670-2677.
203. Watt, G., G. Zaraspe, S. Bautista, and L. W. Laughlin. 1988. Rapid diagnosis of tuberculous meningitis by using an enzyme-linked immunosorbent assay to detect mycobacterial antigen and antibody in cerebrospinal fluid. J Infect Dis 158:681-686.
204. WHO Collaborating Centre for the Surveillance of Tuberculosis in Europe. 2003. Surveillance of Tuberculosis in Europe - Euro TB, p. 1-120. France.
205. Williams, D. L., L. Spring, L. Collins, L. P. Miller, L. B. Heifets, P. R. Gangadharam, and T. P. Gillis. 1998. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 42:1853-1857.
206. Williams, D. L., C. Waguespack, K. Eisenach, J. T. Crawford, F. Portaels, M. Salfinger, C. M. Nolan, C. Abe, V. Sticht-Groh, and T. P. Gillis. 1994. Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 38:2380-2386.
207. Wolinsky, E. 1979. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119:107-159.
208. Woods, G. L., G. Fish, M. Plaunt, and T. Murphy. 1997. Clinical evaluation of difco ESP culture system II for growth and detection of mycobacteria. J Clin Microbiol 35:121-124.
209. World Health Organization. 2000. Anti-Tuberculosis Drug Resistance in The World, p. 1-253, Geneva.
210. World Health Organization. 2000, Guidelines for establishing DOTS-PLUS pilot projects for the management of multidrug resistant tuberculosis (MDR-TB).
211. World Health Organization. 2001. Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for DOTS-PLUS.
212. World Health Organization. 2002. Tuberculosis. WHO information fact sheets 104:1-3.
213. World Health Organization. 2003. Treatment of Tuberculosis: Guidelines for National Programmes, p. 1-108, Geneva.
214. Yang, F., H. Koga, H. Ohno, K. Ogawa, M. Fukuda, Y. Hirakata, S. Maesaki, K. Tomono, T. Tashiro, and S. Kohno. 1998. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother 42:621-628.
215. Yang, Z. Y. Kong, F. Wilson, B. Foxman, A. H. Fowler, C. F. Marrs, M. D. Cav, and J. H. Bates. 2004. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 38:199-205.
216. Zaidi, N. and M. Conner. 2001. Disseminated peritoneal tuberculosis mimicting metastatic ovarian cancer. South Med J 94:1212-1214.
217. Zhang Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalaseperoxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.
218. Zolg, W. and S. Philippi-Schulz. 1994. The superoxide dismutase gene, a target for detection and identification of mycobacteria by PCR. J. Clin Microbiol 32:2801-2812.